Literature DB >> 25052558

Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation.

Amandine Jullienne1, Jill M Roberts2, Viorela Pop1, M Paul Murphy2, Elizabeth Head2, Gregory J Bix2, Jérôme Badaut3.   

Abstract

In our juvenile traumatic brain injury (jTBI) model, emergence of cognitive dysfunctions was observed up to 6 months after trauma. Here we hypothesize that early brain injury induces changes in the neurovascular unit (NVU) that would be associated with amyloid-beta (Aβ) accumulation. We investigated NVU changes for up to 6 months in a rat jTBI model, with a focus on the efflux protein P-glycoprotein (P-gp) and on the basement membrane proteins perlecan and fibronectin, all known to be involved in Aβ clearance. Rodent-Aβ staining is present and increased after jTBI around cerebral blood microvessels, and the diameter of those is decreased by 25% and 34% at 2 and 6 months, respectively, without significant angiogenesis. P-glycoprotein staining in endothelium is decreased by 22% and parallels an increase of perlecan and fibronectin staining around cerebral blood vessels. Altogether, these results strongly suggest that the emergence of long-term behavioral dysfunctions observed in rodent jTBI may be related to endothelial remodeling at the blood-brain barrier alongside vascular dysfunction and altered Aβ trafficking. This study shows that it is important to consider jTBI as a vascular disorder with long-term consequences on cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25052558      PMCID: PMC4269722          DOI: 10.1038/jcbfm.2014.124

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes.

Authors:  Suman Deb; J Wenjun Zhang; Paul E Gottschall
Journal:  Brain Res       Date:  2003-04-25       Impact factor: 3.252

2.  Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.

Authors:  Radosveta Koldamova; Matthias Staufenbiel; Iliya Lefterov
Journal:  J Biol Chem       Date:  2005-10-05       Impact factor: 5.157

3.  Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity.

Authors:  Sarah Wright; Christi Parham; Boyeon Lee; Douglas Clarke; Lisa Auckland; Jennifer Johnston; Andrea L Lawrence; S Kent Dickeson; Samuel A Santoro; Irene Griswold-Prenner; Gregory Bix
Journal:  Neurobiol Aging       Date:  2010-12-03       Impact factor: 4.673

4.  Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.

Authors:  J van Horssen; I Otte-Höller; G David; M L Maat-Schieman; L P van den Heuvel; P Wesseling; R M de Waal; M M Verbeek
Journal:  Acta Neuropathol       Date:  2001-12       Impact factor: 17.088

5.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.

Authors:  Laibaik Park; Ping Zhou; Rose Pitstick; Carmen Capone; Josef Anrather; Erin H Norris; Linda Younkin; Steven Younkin; George Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

6.  Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia.

Authors:  Richard Milner; Stephanie Hung; Bernadette Erokwu; Paula Dore-Duffy; Joseph C LaManna; Gregory J del Zoppo
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

7.  Focal cerebral ischemia induces active proteases that degrade microvascular matrix.

Authors:  Shunichi Fukuda; Catherine A Fini; Takuma Mabuchi; James A Koziol; Leonard L Eggleston; Gregory J del Zoppo
Journal:  Stroke       Date:  2004-03-04       Impact factor: 7.914

8.  Disassembly of amyloid beta-protein fibril by basement membrane components.

Authors:  Yoichi Kiuchi; Yoshihiko Isobe; Kiyomi Fukushima; Masaaki Kimura
Journal:  Life Sci       Date:  2002-04-05       Impact factor: 5.037

9.  Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.

Authors:  David J Loane; Patricia M Washington; Lilit Vardanian; Ana Pocivavsek; Hyang-Sook Hoe; Karen E Duff; Ibolja Cernak; G William Rebeck; Alan I Faden; Mark P Burns
Journal:  J Neurotrauma       Date:  2011-02       Impact factor: 5.269

10.  Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation.

Authors:  D Muir; M Manthorpe
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  17 in total

1.  CX3CR1-CCR2-dependent monocyte-microglial signaling modulates neurovascular leakage and acute injury in a mouse model of childhood stroke.

Authors:  Joel Faustino; Sophorn Chip; Nikita Derugin; Amandine Jullienne; Mary Hamer; Elizabeth Haddad; Oleg Butovsky; Andre Obenaus; Zinaida S Vexler
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-10       Impact factor: 6.200

2.  A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.

Authors:  Todd C Peterson; Michael R Hoane; Keith S McConomy; Fred M Farin; Theo K Bammler; James W MacDonald; Eric D Kantor; Gail D Anderson
Journal:  J Neurotrauma       Date:  2015-02-26       Impact factor: 5.269

Review 3.  Military-related risk factors for dementia.

Authors:  Heather M Snyder; Roxana O Carare; Steven T DeKosky; Mony J de Leon; Derek Dykxhoorn; Li Gan; Raquel Gardner; Sidney R Hinds; Michael Jaffee; Bruce T Lamb; Susan Landau; Geoff Manley; Ann McKee; Daniel Perl; Julie A Schneider; Michael Weiner; Cheryl Wellington; Kristine Yaffe; Lisa Bain; Anthony M Pacifico; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2018-11-08       Impact factor: 21.566

4.  Transforming growth factor-β promotes basement membrane fibrosis, alters perivascular cerebrospinal fluid distribution, and worsens neurological recovery in the aged brain after stroke.

Authors:  Matthew D Howe; J Weldon Furr; Yashasvee Munshi; Meaghan A Roy-O'Reilly; Michael E Maniskas; Edward C Koellhoffer; John d'Aigle; Lauren H Sansing; Louise D McCullough; Akihiko Urayama
Journal:  Geroscience       Date:  2019-11-13       Impact factor: 7.713

5.  Fibronectin induces the perivascular deposition of cerebrospinal fluid-derived amyloid-β in aging and after stroke.

Authors:  Matthew D Howe; Louise A Atadja; J Weldon Furr; Michael E Maniskas; Liang Zhu; Louise D McCullough; Akihiko Urayama
Journal:  Neurobiol Aging       Date:  2018-08-09       Impact factor: 4.673

Review 6.  Response of the cerebral vasculature following traumatic brain injury.

Authors:  Arjang Salehi; John H Zhang; Andre Obenaus
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-05       Impact factor: 6.200

7.  ABCG2 c.421C>A Is Associated with Outcomes after Severe Traumatic Brain Injury.

Authors:  Solomon M Adams; Yvette P Conley; Dianxu Ren; David O Okonkwo; Ava M Puccio; C Edward Dixon; Robert S B Clark; Patrick M Kochanek; Philip E Empey
Journal:  J Neurotrauma       Date:  2017-09-19       Impact factor: 5.269

Review 8.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

Review 9.  Traumatic brain injury-induced autoregulatory dysfunction and spreading depression-related neurovascular uncoupling: Pathomechanisms, perspectives, and therapeutic implications.

Authors:  Peter Toth; Nikolett Szarka; Eszter Farkas; Erzsebet Ezer; Endre Czeiter; Krisztina Amrein; Zoltan Ungvari; Jed A Hartings; Andras Buki; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-09       Impact factor: 4.733

Review 10.  Chronic cerebrovascular dysfunction after traumatic brain injury.

Authors:  Amandine Jullienne; Andre Obenaus; Aleksandra Ichkova; Catherine Savona-Baron; William J Pearce; Jerome Badaut
Journal:  J Neurosci Res       Date:  2016-04-27       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.